Suppr超能文献

癌症转移中的免疫系统:朋友还是敌人?

The immune system in cancer metastasis: friend or foe?

机构信息

Departments of Melanoma Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.

Cancer Biology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.

出版信息

J Immunother Cancer. 2017 Oct 17;5(1):79. doi: 10.1186/s40425-017-0283-9.

Abstract

Metastatic disease is the leading cause of death among cancer patients and involves a complex and inefficient process. Every step of the metastatic process can be rate limiting and is influenced by non-malignant host cells interacting with the tumor cell. Over a century ago, experiments first indicated a link between the immune system and metastasis. This phenomenon, called concomitant immunity, indicates that the primary tumor induces an immune response, which may not be sufficient to destroy the primary tumor, but prevents the growth of a secondary tumor or metastases. Since that time, many different immune cells have been shown to play a role in both inhibiting and promoting metastatic disease. Here we review classic and new observations, describing the links between the immune system and metastasis that inform the development of cancer therapies.

摘要

转移性疾病是癌症患者死亡的主要原因,涉及一个复杂而低效的过程。转移过程的每一步都可能受到限制,并受到与肿瘤细胞相互作用的非恶性宿主细胞的影响。一个多世纪前,实验首次表明免疫系统与转移之间存在联系。这种现象称为伴随免疫,表明原发性肿瘤诱导免疫反应,该反应可能不足以破坏原发性肿瘤,但可防止继发性肿瘤或转移的生长。从那时起,已经有许多不同的免疫细胞被证明在抑制和促进转移性疾病方面发挥作用。在这里,我们回顾了经典和新的观察结果,描述了免疫系统与转移之间的联系,这些联系为癌症治疗的发展提供了信息。

相似文献

1
The immune system in cancer metastasis: friend or foe?
J Immunother Cancer. 2017 Oct 17;5(1):79. doi: 10.1186/s40425-017-0283-9.
2
Immune regulation of metastasis: mechanistic insights and therapeutic opportunities.
Dis Model Mech. 2018 Oct 24;11(10):dmm036236. doi: 10.1242/dmm.036236.
3
Immune cell promotion of metastasis.
Nat Rev Immunol. 2015 Feb;15(2):73-86. doi: 10.1038/nri3789.
4
Immune cells as mediators of solid tumor metastasis.
Cancer Metastasis Rev. 2008 Mar;27(1):11-8. doi: 10.1007/s10555-007-9100-0.
5
Immunoediting: evidence of the multifaceted role of the immune system in self-metastatic tumor growth.
Theor Biol Med Model. 2012 Jul 28;9:31. doi: 10.1186/1742-4682-9-31.
7
Metastases in immune-mediated dormancy: a new opportunity for targeting cancer.
Cancer Res. 2014 Dec 1;74(23):6750-7. doi: 10.1158/0008-5472.CAN-14-2406. Epub 2014 Nov 19.
8
Interleukin 18: friend or foe in cancer.
Biochim Biophys Acta. 2013 Dec;1836(2):296-303. doi: 10.1016/j.bbcan.2013.09.001. Epub 2013 Oct 8.
9
Immunosuppressive cells in tumor immune escape and metastasis.
J Mol Med (Berl). 2016 May;94(5):509-22. doi: 10.1007/s00109-015-1376-x. Epub 2015 Dec 22.
10
A mathematical model for the immune-mediated theory of metastasis.
J Theor Biol. 2019 Dec 7;482:109999. doi: 10.1016/j.jtbi.2019.109999. Epub 2019 Sep 4.

引用本文的文献

1
Breaking Barriers with Sound: The Implementation of Histotripsy in Cancer.
Cancers (Basel). 2025 Aug 1;17(15):2548. doi: 10.3390/cancers17152548.
2
From lab to life: technological innovations in transforming cancer metastasis detection and therapy.
Discov Oncol. 2025 Aug 10;16(1):1517. doi: 10.1007/s12672-025-02910-8.
3
Induction of cancer stem cells from mouse fibroblasts.
Sci Rep. 2025 Jul 15;15(1):25489. doi: 10.1038/s41598-025-09686-5.
4
Elevated tumor NOS2/COX2 promotes immunosuppressive phenotypes associated with poor survival in ER- breast cancer.
JCI Insight. 2025 Jul 15;10(16). doi: 10.1172/jci.insight.193091. eCollection 2025 Aug 22.
6
Bioactive metallic nanoparticles for synergistic cancer immunotherapy.
Acta Pharm Sin B. 2025 Apr;15(4):1869-1911. doi: 10.1016/j.apsb.2025.02.022. Epub 2025 Feb 21.
7
Mechanoimmunological Control of Metastatic Site Selection.
bioRxiv. 2025 May 13:2025.05.10.653256. doi: 10.1101/2025.05.10.653256.
8
Battlegrounds of treatment resistance: decoding the tumor microenvironment.
Naunyn Schmiedebergs Arch Pharmacol. 2025 Mar 25. doi: 10.1007/s00210-025-04055-5.
9
Nanovaccines empowering CD8 T cells: a precision strategy to enhance cancer immunotherapy.
Theranostics. 2025 Feb 10;15(7):3098-3121. doi: 10.7150/thno.107856. eCollection 2025.

本文引用的文献

1
Circulating and disseminated tumor cells: harbingers or initiators of metastasis?
Mol Oncol. 2017 Jan;11(1):40-61. doi: 10.1002/1878-0261.12022.
3
Alarmins and Antitumor Immunity.
Clin Ther. 2016 May;38(5):1042-53. doi: 10.1016/j.clinthera.2016.03.021. Epub 2016 Apr 22.
4
Systemic inflammation: Cancer's long-distance reach to maximize metastasis.
Oncoimmunology. 2015 Aug 17;5(2):e1075694. doi: 10.1080/2162402X.2015.1075694. eCollection 2016 Feb.
5
Tissue factor associates with survival and regulates tumour progression in osteosarcoma.
Thromb Haemost. 2016 May 2;115(5):1025-33. doi: 10.1160/TH15-07-0541. Epub 2016 Jan 14.
6
The Macrophage Inhibitor CNI-1493 Blocks Metastasis in a Mouse Model of Ewing Sarcoma through Inhibition of Extravasation.
PLoS One. 2015 Dec 28;10(12):e0145197. doi: 10.1371/journal.pone.0145197. eCollection 2015.
7
Natural Killer Cell-Based Therapies Targeting Cancer: Possible Strategies to Gain and Sustain Anti-Tumor Activity.
Front Immunol. 2015 Nov 30;6:605. doi: 10.3389/fimmu.2015.00605. eCollection 2015.
9
Pulmonary alveolar macrophages contribute to the premetastatic niche by suppressing antitumor T cell responses in the lungs.
J Immunol. 2015 Jun 1;194(11):5529-38. doi: 10.4049/jimmunol.1403215. Epub 2015 Apr 24.
10
Tumor-derived CD4+CD25+ Tregs inhibit the maturation and antigen-presenting function of dendritic cells.
Asian Pac J Cancer Prev. 2015;16(7):2665-9. doi: 10.7314/apjcp.2015.16.7.2665.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验